Hantavirus Tracker

A multinational outbreak of Andes hantavirus centered on the cruise ship MV Hondius — now 13 cases (11 confirmed, two probable) and three deaths — has prompted WHO and PAHO alerts, multinational evacuations, quarantine and expanded contact tracing and cleaning, with authorities warning more cases may surface because incubation can reach six weeks.

Laboratory analyses showing strong B‑cell neutralizing responses and early preclinical vaccine work offer hope for future vaccines or antibody therapies but are years away, while public health priorities in the near term are timely surveillance, cross‑border coordination, exploitation of a potential post‑exposure treatment window, and countering misinformation that has overstated geographic spread.

Tracking: hantavirus

Geography: United States (Four Corners, New Mexico, Arizona), Canada, Mexico, Argentina, Chile, Bolivia, Paraguay, Brazil, China, South Korea, Russia, Scandinavia (Finland, Sweden), Europe (general, including Germany and the Balkans)

1. Hantavirus outbreak on cruise ship infects 13, WHO says

A multinational cluster of hantavirus infections tied to the cruise ship MV Hondius has risen to 13 cases, the World Health Organization said, including 11 confirmed and two probable infections and three deaths.

Patients and crew from several countries were evacuated, repatriated, tested and placed under quarantine after ports in Argentina and Chile were visited during the Southern Hemisphere summer, and authorities have identified the Andes virus subtype among cases, the only hantavirus known to transmit between humans.

Health authorities say the situation "remains stable" with sick passengers receiving care, while others stay quarantined and under monitoring; the ship's Rotterdam departure was delayed for additional cleaning.

WHO warned more cases are likely because symptoms can take up to six weeks to develop, prompting multinational contact tracing and enhanced cleaning protocols as governments manage repatriation and cross-border surveillance.

Key facts:

- 13 cases linked to MV Hondius cruise ship, WHO reported

- 11 confirmed and two probable infections

- Three deaths: a Dutch couple and a German woman

- Virus implicated: Andes subtype; only hantavirus with human-to-human spread

- MV Hondius visited ports in Argentina and Chile

Why it matters: The cluster tests international outbreak response: coordinated repatriation, quarantine, contact tracing and strain typing are required to detect further cases during the six-week incubation window.

Cruise operators and ports face operational disruption and reputational risk, while public health and One Health programs gain opportunity—and pressure—to clarify Andes virus transmission dynamics; watch for additional case confirmations, Andes strain counts, and patient outcomes.

PoliticoReutersHantavirusreports

2. PAHO issues alert as hantavirus cases rise, cruise ship reports outbreak

PAHO has issued an epidemiological alert after reported increases in hantavirus pulmonary syndrome (HPS) across the Americas, with Argentina reporting 134 confirmed HPS cases in 2024 and Chile 62 during the same period.

The agency highlighted Andes virus as the primary South American agent—capable of person-to-person transmission—and noted seasonal peaks in late spring and summer, recommending strengthened surveillance, laboratory diagnostics, and public awareness.

\n\nSeparately, the MV Hondius cruise ship outbreak has produced 11 confirmed cases, including three deaths; WHO says nine cases involved Andes virus, and a Spanish evacuee tested positive.

Some 147 passengers and crew from over 20 countries are under monitoring as the ship heads to Tenerife; evacuations included personnel in full-body protective gear and disinfection measures, creating a complex global coordination challenge.

Key facts:

- PAHO issued epidemiological alert for rising hantavirus cases in the Americas.

- Argentina reported 134 confirmed HPS cases in 2024.

- Chile documented 62 confirmed HPS cases in 2024.

- Andes virus is primary agent in South America and can transmit human-to-human.

- PAHO recommends stronger surveillance, lab diagnostics, and public awareness.

Why it matters: Converging trends—rising HPS in Argentina and Chile and a multinational cruise-ship cluster—heighten demand for cross-border surveillance, laboratory capacity, and coordinated public health response.

Watch for additional case confirmations, evidence of onward person-to-person spread, and further PAHO/WHO operational guidance that will affect travel, port operations, and regional One Health coordination.

Hantavirusreports

3. Saskatoon researchers begin early animal testing of hantavirus vaccine

Researchers at the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) are conducting early pre‑clinical animal testing of a hantavirus vaccine to measure immune responses and protection, VIDO principal scientist Bryce Warner said.

The work follows a recent luxury cruise ship outbreak earlier this month that killed three people and builds on VIDO’s ongoing studies of New World hantaviruses, notably Andes virus—which spread on the MV Hondius—and Sin Nombre virus, commonly linked to deer‑mouse infections in Canada and the U.S. VIDO is developing a protein subunit vaccine and exploring intranasal or mucosal delivery to trigger lung immunity, because lungs are the typical point of viral entry, Warner said.

There is currently no cure or licensed vaccine for hantavirus, and Warner estimated moving "into people’s arms" will take "probably 10‑plus years," with approvals and funding also affecting rollout.

Key facts:

- VIDO (University of Saskatchewan) in early pre-clinical animal testing of hantavirus vaccine.

- Bryce Warner, VIDO principal scientist, described early pre-clinical trials and goals.

- Recent luxury cruise ship outbreak earlier this month killed three people.

- VIDO focuses on New World hantaviruses: Andes virus and Sin Nombre virus.

- Andes virus spread among passengers on the MV Hondius.

Why it matters: A vaccine targeting Andes and Sin Nombre viruses could directly benefit populations in the Americas where those strains circulate and address outbreaks like the recent cruise-ship cluster.

Intranasal or mucosal delivery aims to block infection at the lungs, a strategic choice given viral entry routes.

However, the quoted "probably 10‑plus years" timeline and the need for approvals and funding mean short-term prevention still relies on surveillance, exposure reduction, and public health messaging; watch preclinical results, funding commitments, and regulatory milestones next.

Globalnews

4. LJI finds strong B‑cell response to Andes hantavirus after cruise outbreak

Researchers at the La Jolla Institute for Immunology analyzed B‑cell responses to Andes hantavirus following an outbreak aboard the cruise ship MV Hondius, using a meta-analysis of datasets in the Immune Epitope Database (IEDB) funded by NIAID.

The team reports hantaviruses can elicit a strong B‑cell response that produces neutralizing antibodies, a finding the authors call encouraging for vaccines and antibody‑based therapies.

Because hantaviruses have a relatively long incubation period, the report highlights a potential post‑exposure window to administer vaccines or monoclonal antibodies.

The analysis stresses that most hantaviruses are rodent‑to‑human only, though Andes virus can spread person‑to‑person, and reminds clinicians and public health officials that rodent saliva, droppings, or urine pose the primary transmission risk.

Key facts:

- La Jolla Institute for Immunology (LJI) led the B‑cell response analysis.

- The analysis was prompted by an outbreak aboard cruise ship MV Hondius.

- Researchers used a meta-analysis of IEDB datasets funded by NIAID.

- LJI found hantaviruses can spur strong B‑cell responses with neutralizing antibodies.

- Alessandro Sette (LJI) said findings support vaccine and antibody‑therapy development.

Why it matters: This immune‑response evidence strengthens the case for developing vaccines and monoclonal antibodies as outbreak tools, especially for exposures with a measurable incubation window.

Public health agencies and clinicians should prioritize rapid diagnostics, therapeutic development, and targeted risk communication about rodent exposure after cluster events (for example, cruise or community outbreaks).

Because Andes virus can transmit between people, authorities must combine traditional rodent‑control messaging with enhanced surveillance and readiness to deploy antibody‑based interventions for exposed contacts.

Lji

5. Viral map falsely implies global hantavirus cases

A widely shared map has been used to falsely claim the Andes hantavirus is rapidly spreading across Europe and North America. Screenshots from HantavirusMap.

com — which aggregates news items and community alerts, not laboratory-confirmed infections — circulated on X and TikTok after an outbreak on the cruise ship MV Hondius and were interpreted as case counts.

Spain has two confirmed cases linked to the MV Hondius, and the European Centre for Disease Prevention and Control’s 26 May update reported 13 total cases (11 confirmed, 2 probable).

The map's creator, Bas Witkop, says the tool shows 'news signals, not confirmed cases' and has added clearer disclaimers and stricter classification; ECDC noted more identifications may occur because of the virus's long incubation, but the risk to the broader EU/EEA population remains very low.

Key facts:

- HantavirusMap.com aggregates news articles and community alerts, not confirmed infections

- Screenshots from the site circulated on X and TikTok after an MV Hondius outbreak

- Spain has two confirmed hantavirus cases linked to MV Hondius

- ECDC 26 May update reported 13 total cases: 11 confirmed, 2 probable

- Site creator Bas Witkop built the tool and added clearer disclaimers afterwards

Why it matters: Treat aggregated online trackers as unverified signals; misreading them inflates perceived spread and risks unnecessary public alarm.

Public-health authorities and clinicians should use official confirmed-case updates (ECDC, national ministries) and watch for delayed identifications driven by the virus's long incubation period.

Euronews